Dimensional Fund Advisors
TGTX icon

Dimensional Fund Advisors’s TG Therapeutics TGTX Stock Holding History

Dimensional Fund Advisors’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$63.6M Sell
1,139,352
-71,226
-6% -$3.85M 0.01% 1442
2026
Q2 		$66.5M Buy
1,210,578
+125,723
+12% +$5.15M 0.01% 1436
2026
Q1 		$36M Buy
1,084,855
+612,068
+129% +$18.2M 0.01% 1684
2025
Q4 		$14.1M Buy
472,787
+446,884
+1,725% +$14.6M ﹤0.01% 2152
2025
Q3 		$936K Buy
+25,903
New +$853K ﹤0.01% 2900
2021
Q3 		– Sell
-31,450
Closed -$1.22M – 3533
2021
Q2 		$1.22M Sell
31,450
-53,803
-63% -$2.11M ﹤0.01% 2993
2021
Q1 		$4.11M Buy
85,253
+79,765
+1,453% +$3.83M ﹤0.01% 2640
2020
Q4 		$285K Buy
+5,488
New +$185K ﹤0.01% 3181
2019
Q1 		– Sell
-71,312
Closed -$292K – 3461
2018
Q4 		$292K Buy
71,312
+6,812
+11% +$33.9K ﹤0.01% 3229
2018
Q3 		$361K Buy
+64,500
New +$737K ﹤0.01% 3223
2015
Q2 		– Sell
-13,089
Closed -$203K – 3372
2015
Q1 		$203K Buy
+13,089
New +$198K ﹤0.01% 3226

Other funds holding TGTX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Penn Capital Management
Penn Capital Management Philadelphia, Pennsylvania $1.37B AUM 42.56% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

Dimensional Fund Advisors's TGTX Position: Q3 2026 in Review

Dimensional Fund Advisors reduced its TG Therapeutics (TGTX) stake by 5.9% in Q3 2026, selling an estimated $3.85M and leaving 1,139,352 shares worth $63.6M. The position accounts for 0.01% of the portfolio, ranked #1442.

Dimensional Fund Advisors first reported a position in TGTX in Q1 2015 and has held it in 11 quarters since. The position peaked at $66.5M in Q2 2026. 197 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.

  • Dimensional Fund Advisors held 1,139,352 shares of TG Therapeutics worth $63.6M as of Q3 2026.
  • Dimensional Fund Advisors sold 71,226 TG Therapeutics shares in Q3 2026, an estimated $3.85M.
  • TG Therapeutics made up 0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #1442 holding.
  • Dimensional Fund Advisors first reported a position in TG Therapeutics in Q1 2015 and has held it in 11 quarters since.
  • Dimensional Fund Advisors's TG Therapeutics position peaked at $66.5M in Q2 2026.
  • 197 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.

Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.